Treatment of breast cancer MDA-MB-231 cells with indinavir resulted in Aurora B and XIAP downregulation and caspase-3 activation, which are the hallmarks of survivin PPI inhibition [152]. The gene discussed is BIRC5; the disease is breast cancer.